APA cuts CME ties with drugmakers

Reformers have snipped yet another financial tie between the pharma industry and doctors. The American Psychiatric Association said it's phasing out industry-sponsored educational programs and industry-funded meals at its meetings. The medical society says drugmaker sponsorship has tainted its programming with fears of bias--so it's bowing out. "We decided to keep education separate from industry support," APA President Nada Stotland told the Psychiatric Times.

The decision culminates a year-plus process of deliberation. The APA set up a working group to look at concerns that the association was too closely tied to the pharma industry. In the end, that task force voted to cut off the pharma spigot, at least to educational programs. The APA will still allow drugmakers to sponsor the associations advertising and to support fellowships and research training, and pharma will still be paying for exhibits at association meetings. Reaction from members has been positive, Stotland said. "I've gotten a few complaints and lot of happy responses," she told the magazine.

- read the Times article

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.